Tag: generic drugs

Explore what bioequivalence testing really proves regarding generic versus brand-name drugs. Learn how regulatory standards ensure safety and efficacy.

Long-term studies show generics are generally as safe as brand-name drugs, but key differences emerge for high-risk medications and certain manufacturers. Learn when switching could affect your health and what to ask your pharmacist.

Bioequivalence standards for generic drugs have long ignored batch-to-batch variability, risking false conclusions. New guidelines now require multi-batch testing to ensure real-world equivalence and patient safety.

Generic drugs work just like brand-name ones but cost up to 85% less. Learn how the FDA ensures they're safe, when to choose them, and why they save billions every year.

The FDA now conducts unannounced inspections of foreign generic drug factories to ensure safety. With 80% of active ingredients made overseas, stricter oversight aims to prevent contamination, falsified data, and unsafe drugs from reaching U.S. patients.

False advertising in generic drugs misleads patients about safety, equivalence, and cost. Learn the legal risks, FDA rules, and how deceptive ads can harm health and trigger lawsuits.

Learn how pharmacy systems accurately distinguish between generic and brand-name drugs using NDC codes, FDA therapeutic equivalence data, and state-specific rules. Best practices for safety, cost savings, and patient trust.